Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Endometrial Carcinoma · Serous Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Qilu Hospital of Shandong University, Jinan, Shandong, China
Contact: Study coordinator (Xi Zhang) · happylittlebrook@163.com · 86-18560082013

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Colorectal Carcinoma · Endometrial Carcinoma · Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Los Angeles, United States

Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

Endometrial Cancer · Cancer of Endometrium · Carcinoma of Endometrium

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

A Beta-only IL-2 ImmunoTherapY Study

Advanced Solid Tumor · Unresectable Solid Tumor · Clear Cell Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Diego, United States · San Francisco, United States

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma · Recurrent Endometrial Carcinoma

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Anchorage, United States